← FDA DRUG APPROVALS

FDA ANDA · ANDA075446

BETAXOLOL HYDROCHLORIDE

Sponsor: APOTEX INC

APPLICATION
ANDA075446
TYPE
ANDA
ORIGINAL APPROVAL
2000-09-28
LATEST ACTION
2015-09-10
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued

Products

BETAXOLOL HYDROCHLORIDEDiscontinued
BETAXOLOL HYDROCHLORIDE EQ 0.5% BASE · SOLUTION/DROPS · OPHTHALMIC

Approval history

2015-09-10Labeling · Supplement 16 · standardAP
2001-10-03Manufacturing (CMC) · Supplement 1AP
2001-08-30Manufacturing (CMC) · Supplement 3AP
2001-07-30Manufacturing (CMC) · Supplement 2AP
2000-09-28OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →